Forte Biosciences
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Forte Biosciences generated cash of -$28,706,000, which is less than the previous year. Cash used in financing activities reached the amount of $24,684,000 last year. Net change in cash is therefore -$3,975,000.
Cash Flow
| 2015 | -21.04M | -24.92M | 49.91M |
|---|---|---|---|
| 2016 | -29.53M | 24.56M | 2.33M |
| 2017 | -31.13M | -27.70M | 89.26M |
| 2018 | -34.46M | -4.19M | 43.53M |
| 2019 | -2.77M | -161.59K | 4.85M |
| 2020 | -18.42M | 3.58M | 66.66M |
| 2021 | -16.67M | 0 | -44K |
| 2022 | -8.18M | 0 | 7.24M |
| 2023 | -28.70M | 47K | 24.68M |
FBRX Cash Flow Statement (2015 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 41.1M | 42.04M | 58.76M | 6.93M | 5.01M | 35.93M | 5.51M | 8.15M | 4.20M |
Operating activities | |||||||||
Net income | -31.47M | -13.87M | -21.70M | -46.48M | -4.06M | -48.95M | -38.92M | -33.47M | -23.05M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||||||
Depreciation and amortization | 9K | 0 | 36K | 54K | 10.99K | 625K | 292K | 255K | 232K |
Stock-based compensation expense | 3.28M | 4.01M | 4.21M | 956K | 35.71K | 0 | 4.45M | 0 | 0 |
| Deferred income tax benefit | 3.28M | 4.01M | 4.21M | 956K | 35.71K | 0 | 4.45M | 0 | 0 |
| Changes in operating assets and liabilities: | |||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 271K | 207K | -294K | -369K | 976.10K | -1.45M | 304K | -366K | 571K |
Cash generated by operating activities | -28.70M | -8.18M | -16.67M | -18.42M | -2.77M | -34.46M | -31.13M | -29.53M | -21.04M |
Investing activities | |||||||||
Purchases Of Investments | -9.96M | 0 | 0 | 0 | 0 | -70.74M | -70.79M | 0 | -59.87M |
Investments In Property Plant And Equipment | -88K | 0 | 0 | 0 | -161.59K | -1.96M | -655K | -525K | -231K |
Acquisitions Net | 0 | 0 | 0 | 3.58K | 0 | 2.22M | 20K | 0 | 15K |
Cash generated by investing activities | 47K | 0 | 0 | 3.58M | -161.59K | -4.19M | -27.70M | 24.56M | -24.92M |
Financing activities | |||||||||
Common Stock Issued | 24.72M | 7.22M | 62K | 66.69M | 4.85M | 661K | 89.12M | 0 | 157K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 28.86M | 89K | 3.38M | 33.23M |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 | 0 | 138K | 0 | 50.74M |
Cash used in financing activities | 24.68M | 7.24M | -44K | 66.66M | 4.85M | 43.53M | 89.26M | 2.33M | 49.91M |
Net Change In Cash | -3.97M | -944K | -16.72M | 51.82M | 1.92M | 4.88M | 30.42M | -2.64M | 3.94M |
Cash at end of period | 37.12M | 41.1M | 42.04M | 58.76M | 6.93M | 40.81M | 35.93M | 5.51M | 8.15M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source |